Evidence map›Paper›PMID 27068747›Full record

ArticleThe Journal of biological chemistry2016

Transcription Factor hDREF Is a Novel SUMO E3 Ligase of Mi2α.

Daisuke Yamashita, Takanobu Moriuchi, Takashi Osumi, Fumiko Hirose

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Three Copies ofBiology · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?International journal of molecular sciences · 2021
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. The role of SUMOylation during development.Biochemical Society transactions · 2020
    Review
  13. Article
  14. Article
  15. High expression of ZBED1 affects proliferation and apoptosis in gastric cancer.International journal of clinical and experimental pathology · 2018
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Daisuke YamashitaFrom the Graduate School of Life Science, University of Hyogo, 3-2-1 Koto, Kamigori, Hyogo 678-1297, Japan.
Takanobu MoriuchiFrom the Graduate School of Life Science, University of Hyogo, 3-2-1 Koto, Kamigori, Hyogo 678-1297, Japan.
Takashi OsumiFrom the Graduate School of Life Science, University of Hyogo, 3-2-1 Koto, Kamigori, Hyogo 678-1297, Japan.
Fumiko HiroseFrom the Graduate School of Life Science, University of Hyogo, 3-2-1 Koto, Kamigori, Hyogo 678-1297, Japan fhirose@sci.u-hyogo.ac.jp.
University of Hyogo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human transcription factor DNA replication-related element-binding factor (hDREF) is essential for the transcription of a number of housekeeping genes. The mechanisms underlying constitutively active transcription by hDREF were unclear. Here, we provide evidence that hDREF possesses small ubiquitin-like modifier (SUMO) ligase activity and can specifically SUMOylate Mi2α, an ATP-dependent DNA helicase in the nucleosome remodeling and deacetylation complex. Moreover, immunofluorescent staining and biochemical analyses showed that coexpression of hDREF and SUMO-1 resulted in dissociation of Mi2α from chromatin, whereas a SUMOylation-defective Mi2α mutant remained tightly bound to chromatin. Chromatin immunoprecipitation and quantitative RT-PCR analysis demonstrated that Mi2α expression diminished transcription of the ribosomal protein genes, which are positively regulated by hDREF. In contrast, coexpression of hDREF and SUMO-1 suppressed the transcriptional repression by Mi2α. These data indicate that hDREF might incite transcriptional activation by SUMOylating Mi2α, resulting in the dissociation of Mi2α from the gene loci. We propose a novel mechanism for maintaining constitutively active states of a number of hDREF target genes through SUMOylation.

Indexed as

Gene Expression RegulationSumoylationAutoantigensBlotting, WesternChromatin ImmunoprecipitationDNA ReplicationFluorescent Antibody TechniqueHeLa CellsHumansImmunoenzyme TechniquesImmunoprecipitationMi-2 Nucleosome Remodeling and Deacetylase ComplexPromoter Regions, GeneticProtein BindingProtein Processing, Post-TranslationalReal-Time Polymerase Chain ReactionAutoantigensCHD4 protein, humanMi-2 Nucleosome Remodeling and Deacetylase ComplexRNA, MessengerRNA, Small InterferingSmall Ubiquitin-Related Modifier ProteinsTranscription FactorsZBED1 protein, humanE3 SUMO ligasegene regulationhDREFMi2alphanucleosome remodeling deacetylase (NuRD)sumoylationtranscription factortranscription regulation

Identifiers

PMID27068747
PMCPMC4882432
OpenAlexW2320178525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.